Atezolizumab: A New Hope for Endometrial Cancer Patients

19 Visioni

  • Grazie! Condividilo con i tuoi amici!

    Non hai gradito questo video. Grazie per il feedback!

admin
Published
In a groundbreaking study presented at the ESMO Congress, atezolizumab, when combined with chemotherapy, showed promising results for endometrial cancer patients. While overall survival rates were noninferior compared to placebo, a significant improvement was observed in patients with dMMR carcinomas. The study's dual primary endpoints, progression-free survival and overall survival, were met, with atezolizumab demonstrating enhanced PFS outcomes. Join us as we delve into the details of this research, its implications, and the potential it holds for advanced or recurrent endometrial cancer treatment.
Categoria
Oncology
Commenta per primo questo video.

Prossimo